Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis.
Reske JJ, Wilson MR, Holladay J, Siwicki RA, Skalski H, Harkins S, Adams M, Risinger JI, Hostetter G, Lin K, Chandler RL.
Reske JJ, et al. Among authors: risinger ji.
PLoS Genet. 2021 Dec 23;17(12):e1009986. doi: 10.1371/journal.pgen.1009986. eCollection 2021 Dec.
PLoS Genet. 2021.
PMID: 34941867
Free PMC article.